Obesity-associated inflammation is characterized by recruitment of macrophages (MF) into white adipose tissue (WAT) and production of inflammatory cytokines, leading to the development of insulin resistance. The xanthones, a-and g-mangostin (MG), are major bioactive compounds found in mangosteen that are reported to have antiinflammatory and antioxidant properties. Thus, we examined the efficacy of MG to prevent lipopolysaccharide (LPS)-mediated inflammation in human MF (differentiated U937 cells) and cross-talk with primary cultures of newly differentiated human adipocytes.
Introduction
The increasing incidence of obesity and its associated morbidities has become a major public health concern worldwide [reviewed in (1) ]. Obesity is associated with a chronic, low-grade inflammation characterized by macrophage (MF) 6 infiltration into white adipose tissue (WAT) (2, 3) . MF contribute substantially to WAT inflammation (4) . Proinflammatory factors secreted from MF not only induce WAT inflammation but also impair insulin signaling, leading to insulin resistance (5, 6) . Several studies reported that MF are recruited to WAT via monocyte chemoattractant protein (MCP)-1 and are the major source of proinflammatory cytokine production that contributes to systemic inflammation and insulin resistance in obese subjects (7) (8) (9) (10) . Notably, obese individuals have high circulating and tissue levels of inflammatory markers such as tumor necrosis factor-a (TNFa), interleukin (IL)-6, and MCP-1 (11, 12) .
Diet-induced obesity increases plasma levels of lipopolysaccharide (LPS) that contribute to inflammation and insulin resistance (13) . LPS activates toll-like receptor-4 signaling in MFs, triggering an inflammatory signaling cascade, including mitogen-activated protein kinases (MAPK), nuclear factor-kB (NF-kB), and activator protein (AP)-1, which together induce the transcription of proinflammatory cytokines such as TNFa and IL-6, contributing to inflammation and insulin resistance in WAT (13) (14) (15) . Furthermore, LPS has been reported to reduce the expression and function of PPARg, a transcription factor that transrepresses inflammatory gene transcription by antagonizing NF-kB and AP-1 activity in MF and adipocytes (14) (15) (16) (17) . In support of these findings, PPARg-deficient MF have increased expression of inflammatory markers and insulin resistance (18, 19) . Thus, preventing the activation of MAPK, NF-kB, or AP-1 in MF may attenuate obesity-associated inflammation and insulin resistance.
The consumption of fruits or fruit extracts rich in phytochemicals may prevent the development of obesity-related inflammation and insulin resistance. Garcinia mangostana (mangosteen) is a tropical fruit native to Southeast Asia used as a traditional medicine (20) . Recently, mangosteen products have become increasingly popular as functional foods and dietary supplements because of their health benefits (21, 22) . The major xanthones found in mangosteen, a-and g-mangostin (MG), have been reported to exert antioxidant and antiinflammatory effects (21, (23) (24) (25) (26) . For example, a-and g-MG reduced inflammation in LPS-stimulated RAW 264.7 murine MF and C6 rat glioma cells by inhibiting NF-kB (24) (25) (26) . Moreover, a-and g-MG showed antiinflammatory activity in an animal model of acute inflammation (24, 26) . Therefore, a-and g-MG could potentially prevent MF-mediated chronic inflammation and insulin resistance in WAT. However, the efficacy of MG to inhibit inflammation in human MF and prevent inflammation and insulin resistance in primary human adipocytes treated with conditioned media (CM) from activated MF, and its mechanism of action, are unknown.
In this study, we examined the ability of a-and g-MG to prevent LPS-mediated induction of inflammatory genes and activation of MAPK, NF-kB, and AP-1 in human MF. Furthermore, we investigated the extent to which MG blocked MFmediated inflammation and insulin resistance in primary human adipocytes.
Materials and Methods
Materials. All cell culture materials were purchased from Fisher Scientific. Fetal bovine serum was purchased from Hyclone. RPMI 1640 was purchased from ATCC. Tri-Reagent was purchased from Molecular Research Center. Gene-specific primers were purchased from Applied Biosystems. Polyclonal antibody for anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was purchased from Santa Cruz Biotechnology. Anti-phospho (Thr180/Typ182) p38 antibody was purchased from BD Bioscience Pharmingen. Anti-inhibitory kappa B protein (IkB)-a, anti-phospho (Ser217/221) and total MAPK kinase (MEK), anti-phospho (Thr183/Tyr185) and total c-Jun NH 2 -terminal kinase (JNK), anti-phospho (Thr202/Tyr204) and total extracellular signalrelated kinase (ERK), total p38, anti-phospho (Ser63) and total c-Jun, anti-phospho (Ser383) Elk-1, and anti-phospho (Thr71) activating transcription factor (ATF)-2 antibodies were purchased from Cell Signaling Technologies. Immunoblotting buffers and precast gels were purchased from Invitrogen. Western Lightning chemiluminescence substrate was purchased from Perkin Elmer Life Science. All other reagents and chemicals were purchased from Sigma Chemical unless otherwise stated.
Culturing of human MF. Human U937 monocytes were purchased from ATCC. Cells were seeded at 0.75 3 10 6 cells/35-mm dishes or 1.25 3 10 6 cells/60-mm dishes and differentiated with 30 mg/L phorbol 12-myristate for 24 h in RPMI 1640 (containing 10% fetal bovine serum, 60 kU/L penicillin, 60 U/L streptomycin, and 25 mg/L amphotericin B). Media were then changed to phorbol 12-myristate-free, RPMI 1640 and 24 h later, the experiments were initiated with the MF monolayers. Cultures were incubated at 378C in a humidified O 2 :CO 2 (95:5%) atmosphere.
Culturing of primary human adipocytes. Abdominal subcutaneous WAT was obtained from nondiabetic females between the ages of 20 and 50 y with a BMI ,32.0 during abdominoplasty. Approval was obtained from the Institutional Review Board at the University of North Carolina at Greensboro and the Moses Cone Memorial Hospital in Greensboro, NC. Tissue was digested using collagenase and stromal vascular (SV) cells were isolated and cultured as previously described (27) . Briefly, SV cells were induced to differentiate in adipocyte medium purchased from Zen-Bio plus 250 mmol/L isobutylmethylxanthine and 1 mmol/L of the thiazolidinedione (TZD) Rosiglitazone (BRL 49653) for 3 d and then grown in adipocyte medium for 3-9 d. Rosiglitazone was a generous gift from Dr. Per Sauerberg, Novo Nordisk, Denmark. Cultures containing ;50% preadipocytes and ;50% adipocytes, based on visual observations, were treated between d 6 and 12 of differentiation. Each experiment was repeated at least twice at different independent experimental times using a mixture of cells from 2 or 3 participants unless otherwise indicated. One representative experiment and statistical analyses are shown.
Preparation of MG. a-MG (98% purity) and g-MG (95% purity) were purified as previously described (28) . Both isomers of MG were dissolved in dimethyl sulfoxide (DMSO) to make 100-mmol/L stock solutions, stored at 2208C, and diluted immediately before use.
RNA isolation and real-time quantitative PCR. Following treatment, cultures were harvested and total RNA was isolated using Tri-Reagent according to the manufacturer's protocol. For real-time quantitative PCR (qPCR), 2.0 mg total RNA was converted into first-strand cDNA using Applied Biosystems High-Capacity cDNA Archive kit. qPCR was performed in an Applied Biosystems 7500 FAST Real-Time PCR system using Taqman Gene Expression assays. To account for possible variation related to cDNA input or the presence of PCR inhibitors, the endogenous reference gene GAPDH was simultaneously quantified for each sample and data were normalized accordingly.
Immunoblotting. Following treatment, cultures were harvested and immunoblotted as previously described (27) . Briefly, total cellular protein was harvested using PBS (pH 7.5) lysis buffer containing 1% nonidet, 0.1% SDS, 0.5% SDS, 30 mL/mL aprotinin, 1 mmol/L phenylmethylsulfonyl fluoride, and 1 mmol/L sodium orthovanadate. The samples were incubated on ice with frequent vortexing, centrifuged for 20 min at 15,000 3 g, and stored at -808C. The protein concentration was determined using the bicinchoninic acid assay. The 20 mg of total cellular protein was separated by electrophoresis on 4-12% SDS-polyacrylamide gradient gels (NuPAGE mini-gel system; Invitrogen), transferred to a polyvinylidene difluoride membrane using a wet transfer module (TransBlot Module; Bio-Rad,), and prepared for immunodetection. Following primary and secondary antibody exposure, each protein was detected using Western Lightning (PE Life Sciences) chemiluminescence substrate. Chemiluminescence was visualized following exposure of the membrane to X-ray film (X-OMAT; Eastman Kodak).
MF-CM experiments in primary human adipocytes. CM was collected from MF cultures pretreated for 2 h with or without 30 mmol/L g-MG followed by treatment for 3 h with 100 mg/L LPS. MF-CM obtained from each experiment was pooled and stored at 2808C until used. For RNA isolation and qPCR experiments, primary human SV cells were seeded at 0.5 3 10 6 /35-mm dish and allowed to differentiate for 6 d. On d 6, media were changed and cells were incubated in 1 mL of adipocyte media. Twenty-four hours later, 1 mL of the following treatments were added to the cultures: 1) fresh RPMI (control); 2) LPSchallenged MF-CM; or 3) LPS-challenged MF-CM pretreated with g-MG. The duration of the MF-CM treatment varied depending on the outcome measured.
2-[
3 H]deoxy-glucose uptake. Primary human adipocytes in 35-mm dishes were incubated on d 12 of differentiation with low glucose (1000 mg/L)-and insulin (20 pmol/L)-containing media for 24 h. Cultures were then treated for 24 h with fresh RPMI (control), LPS-challenged MF-CM, or LPS-challenged MF-CM pretreated with g-MG. Basal and insulinstimulated glucose uptakes were measured as described previously (29) .
Statistical analysis. Statistical analyses were performed for data in Figures 1 and 4 by testing the main effects of MG dose (2 or +) and LPS
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(2 or +) and their interaction (MG 3 LPS) using 2-way ANOVA (SPSS version 16 for Windows, SAS Institute). A 1-way ANOVA was conducted for data in Figure 5 . Duncan's tests were used to compute individual pairwise comparisons of least square means (P , 0.05). Data are expressed as means 6 SEM.
Results a-and g-MG decrease LPS-induced inflammatory gene expression in MF. A preliminary time course study showed that 100 mg/L LPS treatment for 3 h robustly increased inflammatory gene expression and that 30 mmol/L g-MG attenuated this LPS response without reducing MF viability (i.e. no visible difference in the number of adherent or floating cells or in cell morphology) (data not shown). Therefore, we examined the extent to which a 2-h pretreatment with 3, 10, or 30 mmol/L a-and g-MG attenuated markers of inflammation induced by a 3-h treatment with 100 mg/L LPS. The a-and g-MG attenuated LPS-induced increases in the expression of IL-6, TNFa, and interferon (IFN) g-inducible protein (IP)-10 in a dose-dependent manner in human MF (Fig. 1A-F) .
a-and g-MG decrease LPS-mediated activation of MEK and MAPK in MF. Given the important role of MEK, an upstream kinase of MAPK, and MAPK in activating transcription factors that induce inflammatory gene expression, the effects of a-and g-MG on MEK and MAPK phosphorylation in MF were examined. A preliminary time course study showed that 100 mg/L LPS treatment for 30 min markedly increased MAPK phosphorylation (data not shown). Thus, MF were pretreated for 2 h with 10 or 30 mmol/L a-and g-MG and stimulated for 30 min with 100 mg/L LPS. We found that a-and g-MG attenuated LPS phosphorylation of MEK, JNK, ERK, and p38 (Fig. 2) .
MG decreases LPS-mediated activation of NF-kB and AP-1 in MF.
Based on the roles that NF-kB and AP-1 (i.e. c-Jun, ATF-2, Elk-1) play in the transcriptional activation of inflammatory genes, we investigated the effects of a-and g-MG on the activation of these proteins in human MF. MF were pretreated for 2 h with 10 or 30 mmol/L a-and g-MG and then stimulated for 30 min with 100 mg/L LPS. Pretreatment with g-MG, but not a-MG, attenuated LPS-mediated IkB-a degradation (Fig. 3) . Pretreatment with a-and g-MG attenuated LPS-stimulated phosphorylation of c-Jun, a component of AP-1 and a downstream target of JNK (Fig. 3) . Lastly, a-and g-MG pretreatment attenuated LPS phosphorylation of Elk-1 and ATF-2, which are downstream targets of ERK and p38, respectively (Fig. 3) . a-and g-MG attenuate LPS-suppressed PPARg gene expression in MF. Because PPARg plays a crucial role in the transcriptional repression of inflammatory genes, we examined the effects of a-and g-MG on PPARg gene expression in human MF. MF were pretreated for 2 h with 3, 10, or 30 mmol/L a-and g-MG and stimulated for 3 h with 100 mg/L LPS. Pretreatment with a-and g-MG attenuated LPS suppression of PPARg gene expression in a dose-dependent manner (Fig. 4A,B) . In addition, pretreatment with 10 and 30 mmol/L a-and g-MG alone increased PPARg gene expression (Fig. 4A,B) .
g-MG decreases MF-mediated inflammation and insulin resistance in primary human adipocytes. Several studies have shown that MF-secreted factors cause inflammation and insulin resistance in adipocytes (5, 6) . Therefore, we hypothesized that MG pretreatment of MF would prevent MF-CM-mediated inflammation and insulin resistance in human adipocytes. We chose to examine g-MG, because it appeared to be more potent than a-MG. Indeed, 30 mmol/L g-MG pretreatment attenuated MF-mediated induction of inflammatory gene expression, including TNFa, IL-1b, IL-6, IL-8, and MCP-1 in human adipocytes (Fig. 5A-E) . Consistent with these data, 30 mmol/L g-MG pretreatment blocked MF-CM-mediated impartment of insulin-stimulated glucose uptake in primary human adipocytes (Fig. 5F ).
Discussion
In this study, we demonstrated in human MF that: 1) a-and g-MG attenuated LPS-induced expression of IL-6, TNFa, and IP-10 (Fig. 1); 2) a-and g-MG attenuated LPS activation of MEK, JNK, ERK, and p38 (Fig. 2); 3) g-MG, but not a-MG, attenuated LPS-mediated IkB-a degradation (Fig. 3) ; 4) a-and g-MG decreased LPS activation of c-Jun, Elk-1, and ATF-2 (Fig.  3) ; and 5) a-and g-MG attenuated LPS suppression of PPARg gene expression (Fig. 4) . Furthermore, g-MG prevented MF-CM from inducing inflammatory gene expression (Fig. 5A-E) and impairing insulin-stimulated glucose uptake in primary human adipocytes (Fig. 5F ). Taken together, these new findings demonstrate that MG, especially g-MG, inhibits LPS-mediated activation of inflammatory MAPK, transcription factors, and genes in human MF that cause inflammation and insulin resistance in human adipocytes.
Consistent with our findings in human MF, a-or g-MG decreased inflammation in murine MF (24), C6 rat glioma cells (26) , human adipocytes (30) , and mice (24, 26) . Notably, the consumption of mangosteen juice blend containing MG reduced C-reactive protein levels, a biomarker of inflammation, in obese subjects compared with placebo controls (31) . Notably, consuming a xanthone-rich, MG beverage containing 100 mg/L a-MG increased a-MG plasma concentrations to 0.1 mmol/L in healthy humans within 1 h (23). MG absorption increased in a dose-dependent manner and was associated with increased oxygen radical absorbance capacity. Using a simulated digestive system, Bumrungpert et al. (28) demonstrated that xanthones are digested in the gut lumen and incorporated into micelles. They are then taken up by enterocytes, incorporated into chylomicrons, transported across the basolateral membrane, and delivered to peripheral tissues. Alternatively, MG may be metabolized by Phase I-II enzymes into conjugated forms and then transported peripherally (28 toll-like receptor-4, stimulates several intracellular signaling pathways, including MAPK, NF-kB, and AP-1, as well as reduces PPARg expression or activity in MF, leading to increased expression of TNFa, IL-1b, and IL-6 (14, 15, 32) . NF-kB activation is considered to be a key pathway for the regulation of inflammatory cytokine expression. We previously demonstrated that g-MG, but not a-MG, attenuates LPSmediated IkB-a degradation and NF-kB transcriptional activity in human adipocytes (30) . Consistent with this study, we have shown that g-MG, but not a-MG, decreased LPS-activated IkB-a degradation, an indicator of NF-kB activation. These results suggest that MG-mediated inhibition of NF-kB signaling contributes to the decreased expression of inflammatory cytokines in LPS-treated human MF.
Activation of AP-1 transcription family members such as c-Jun, Elk-1, and ATF-2 is regulated by phosphorylation from the upstream kinases JNK, ERK, and p38, respectively (33, 34) , Thus, we examined the extent to which a-and g-MG prevented LPS-mediated activation of these proteins. Consistent with our hypothesis, a-and g-MG attenuated LPS-mediated phosphorylation of these MAPK and their downstream transcription factors. Taken together, these data suggest that MG-mediated inhibition of AP-1 contributes to the decreased expression of inflammatory cytokines in LPS-stimulated human MF.
PPARg plays an important role in stimulating glucose uptake and lipogenesis. Thus, high affinity PPARg ligands like TZD have been developed for controlling insulin resistance and type 2 diabetes (35) . PPARg is also a negative regulator of MF activation and a suppressor of inflammatory gene expression (17) (18) (19) . Notably, PPARg activation antagonizes inflammation by transrepressing NF-kB and MAPK and vice versa. Because LPS suppresses PPARg gene expression in MF (15), we examined the extent to which a-and g-MG could decrease this adverse effect. Indeed, a-and g-MG attenuated LPSmediated suppression of PPARg expression. Interestingly, a-and g-MG alone increased PPARg gene expression in human MF. These data suggest that MG-mediated increases in PPARg expression contribute to the decreased expression of inflammatory cytokines in LPS-treated human MF.
MG may also suppress inflammation by inhibiting MyD88-independent IFN regulatory transcription factor (IRF)-3/IFNb signaling in human MF. Support for this hypothesis comes from our data showing that MG blocks LPS-mediated expression of IP-10, which is an inflammatory chemokine regulated by MyD88-independent IRF-3/IFNb signaling (14, 36) . Thus, MG may attenuate LPS-mediated induction of IP-10 expression by inhibiting MyD88-independent IRF3/IFNb signaling in human MF. Future studies are needed to examine this possibility.
MF-secreted factors that induce inflammation and impair insulin sensitivity in adipocytes have been reported. For example, MF-CM increased the transcript levels of inflammationrelated genes such as MCP-1, IL-6, intercellular adhesion molecule-1, and E-selectin by activating NF-kB in 3T3-L1 adipocytes (37) . Furthermore, U937 monocyte adhesion to 3T3-L1 adipocytes was activated by MF-secreted factors. MF-CM treatment decreased insulin-stimulated glucose uptake in 3T3-L1 adipocytes (5) . In addition, MF-CM blocked insulin action in adipocytes via downregulation of insulin receptor substrate-1, leading to decreased Akt phosphorylation and impaired insulinstimulated glucose transporter-4 translocation to the plasma membrane (6) .
The results of our study demonstrated that MF-mediated inflammation and insulin resistance in adipocytes is prevented by MG similar to that of TZD and lipid-lowering statins. For example, pretreatment of U937 MF with pioglitazone reduced MF-CM-induced inflammation in human Simpson-GolabiBehmel Syndrome adipocytes (37) . Moreover, pretreatment of RAW 264.7 MF with a statin suppressed its CM from inducing proinflammatory genes in 3T3-L1 adipocytes (38) . Similarly, our data showed that pretreatment of human MF with MG decreases their ability to cause inflammation and insulin resistance in human adipocytes. Accordingly, our data from this study and our previous study (30) suggest that MG has antiinflammatory and insulin-sensitizing properties, at least in vitro.
Taken together, these data demonstrate that a-or g-MG attenuates LPS activation of MAPK, NF-kB, and AP-1 and suppression of PPARg that leads to the induction of inflamma- tory genes in human MF. Moreover, the ability of MF-CM to cause inflammation and insulin resistance in human adipocytes is prevented by pretreating MF with g-MG. However, in vivo studies supplementing obese humans or animals with MG are needed to determine the extent to which these in vitro data can be replicated in vivo.
